To keep up-to-date with discussions you can subscribe to all postings by clicking the subscribe button below. You can manage your network notifications and set the frequency of emails in your communication preference area.
Return to previous page
EIPG Sept Newsletter
Dear Colleagues, Please find above the monthly newsletter of EIPG (September 2018). . In this issue, you will find a very interesting article proposed from our colleague Amon Wafelman, from the Nederlandse Industrie-Apothekers (NIA) on the "The Dutch approach to expensive medicines". In the Netherlands the debate on high prices of medicines is very hot, and some hospitals are trying to manufacture expensive drugs in their internal pharmacies in order to keep prices under control. You can also find an update of the regulators' preparations regarding Brexit. While in the UK MHRA will not be longer considered to sign assessment contracts with EMA, the Dutch authority (MEB) is closing collaboration agreements with small European countries to reinforce their regulatory capabilities and future role as Reference Member States. Actions have also been planned by the HMA/EMA Task Force for the availability of medicines. At the monthy update from EIPG, Jane Nicholson presents, a report of a session at the 2018 FIP Congress in Glasgow under the title "Global Harmonisation of Quality Standards for Medicines". Par Tellner (ex-Vice-President at EIPG) has reported about ICH's activities on the Global Harmonisation of Quality Standars for Medicines at the 2018 FIP Congress in Glasgow, including the process for the selection of new topics to be addressed and challenges and opportunities for the future of the association. Should you want to be the next country to present the most interesting pharmaceutical topic of yours in the upcoming issues of EIPG's newsletter, do not hesitate to contact me.
Need help with networks?
If you have any queries about our networks you can get in touch via:
Networks – [email protected]
Local Practice Forums (LPFs) - [email protected]
If you need to report a post then please use the report button within a discussion.